Benzinga | Jun 15, 2021 07:35AM EDT

Raymond James Initiates Coverage On Exact Sciences with Strong Buy Rating, Announces Price Target of $160

Raymond James analyst Andrew Cooper initiates coverage on Exact Sciences (NASDAQ:EXAS) with a Strong Buy rating and announces Price Target of $160.